Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial

Müge Çevik(University of St Andrews), Borisov Se, Zamzurina Abu Bakar, Mookho Malahleha(University of Cape Town), Stephen H. Gillespie(University of St Andrews), Angela M. Crook(MRC Clinical Trials Unit at UCL), Marika Eristavi(National Center for Tuberculosis and Lung Disease), Juliano Timm, Valéria C. Rolla(Unknown), Margareth Pretti Dalcolmo(Fundação Instituto de Pesca do Estado do Rio de Janeiro), Mengchun Li, Nosipho Ngubane, Melvin Spigelman(TB Alliance), Suzanne Staples, Mohammed Rassool(Helen Joseph Hospital), Paul Bruinenberg, Caryn M. Upton(Task Applied Science), Lindsay C Thompson(MRC Clinical Trials Unit at UCL), Jerry Nedelman, Priya Solanki(University College London), Derek J. Sloan(University of St Andrews), Matthew Bates(University of Lincoln), Umesh Lalloo(Wentworth Hospital), Louise Choo, Vincent M. Balanag(Lung Center of the Philippines), Sergey Skornyakov(Ural research Institute of Phthisiopulmonology), Francesca Conradie(University of the Witwatersrand), Janice Caoili(Makati Medical Center), Ebrahim Variava(Kalafong Hospital), George PrayGod(National Institute for Medical Research), Anastasia Samoilova(Sechenov University), Blandina T. Mmbaga(College of African Wildlife Management), Stella M. Fabiane(MRC Clinical Trials Unit at UCL), Morounfolu Olugbosi, Maria Beumont, Leandra Leandra, Ntokozo Zuma-Gwala, Robert Hunt(Unknown), Harriett Mayanja-Kizza, Matt Betteridge(TB Alliance), Niyanda Elias Ntinginya(Mbeya University of Science and Technology), Cheryl Louw, Eugene Sun(TB Alliance), Shakira Rajaram, Genevive Wills, Rodney Dawson(University of Cape Town), Frederick Haraka(Ifakara Health Institute), Timothy D. McHugh(The Royal Free Hospital)
The Lancet Infectious Diseases
May 17, 2024
10.1016/s1473-3099(24)00223-8
Cited by 60

Related Papers

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
|The Lancet Microbe|2020|1.5k
Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial
|The Lancet|2009|1.1k
Virology, transmission, and pathogenesis of SARS-CoV-2
|BMJ|2020|788
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
|New England Journal of Medicine|2014|653